Pharma stocks crater as investors brace for billions in heartburn drug litigation charges

Pharma stocks crater as investors brace for billions in heartburn drug litigation charges

Shares of GlaxoSmithKline, Sanofi and Haleon all sold off sharply this week, shedding tens of billions in market value, amid investor fear over potential US litigation charges focused on popular heartburn drug Zantac. This has been a known issue bubbling in the background for years but investor concern exploded this week in the lead-up to …

Pharma stocks crater as investors brace for billions in heartburn drug litigation charges Read More »